Cutler Bay, FLNCT07214571Now EnrollingIRB Ready

Respiratory Syncytial Virus Infections Clinical Trial in Cutler Bay, FL

Access cutting-edge respiratory syncytial virus infections treatment through this clinical trial at a research site in Cutler Bay. Study-provided care at no cost to qualified participants.

Sponsored by Shionogi

Quick Self-Assessment

See if you qualify for this Cutler Bay location

Preparing your pre-screening questions…

Expert Care in Cutler Bay

Access respiratory syncytial virus infections specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related respiratory syncytial virus infections treatment provided free

Apply for This Cutler Bay Location

Check if you qualify for this respiratory syncytial virus infections clinical trial in Cutler Bay, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cutler Bay

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cutler Bay site if eligible
  4. 4Begin participation

About This Respiratory Syncytial Virus Infections Study in Cutler Bay

The main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.

Sponsor: Shionogi

Who Can Participate

Inclusion Criteria

Participants who have new onset or worsening (if present chronically) of at least 1 of the following signs and/or symptoms consistent with a viral acute respiratory infection within 72 hours prior to randomization: fever, nasal congestion, nasal discharge, sore throat, cough, sputum production, shortness of breath, or wheezing.
Participants diagnosed with RSV infection preferably using a rapid polymerase chain reaction (PCR) or other molecular-based diagnostic assay.
Has at least 1 of the following risk factors for severe RSV disease:
≥ 75 years of age;
Chronic lung disease that is symptomatic and requiring chronic treatment; and
Chronic cardiovascular disease that is symptomatic and requiring chronic treatment.
With the exception of the RSV disease, medically stable on the basis of medical history, physical examination, vital signs, and 12-lead electrocardiogram (ECG) performed at screening. Key

Exclusion Criteria

Hospitalized or expected to be hospitalized within 24 hours of screening.
Is considered by the investigator to be immunocompromised, due to an underlying medical condition or medical therapy, chemotherapy, radiation, stem cell or solid organ transplant.
Has known allergies, hypersensitivity, or intolerance to S-337395 or to any of the excipients of the S-337395 or placebo formulation.
Suspicion or known severe renal impairment.
Any other medical or psychiatric condition making the participant unsuitable for the current study or interfering with the evaluation of response to the study intervention in the opinion of the investigator/subinvestigator.
Has received a therapy intended to treat RSV infection within 14 days prior to screening.
Is receiving chemotherapy or immunotherapy for malignancy.
Has received RSV vaccination within 7 days prior to screening.
Has had either confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or influenza infection (test was positive) during the 28 days prior to screening.
Has any other confirmed clinically relevant respiratory infection by any pathogen at, or within 28 days of screening. Note: Other protocol-specified inclusion and exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cutler Bay?

Yes, this clinical trial (NCT07214571) has an active research site in Cutler Bay, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Respiratory Syncytial Virus Infections Treatment Options in Cutler Bay, FL

If you're searching for respiratory syncytial virus infections treatment options in Cutler Bay, FL, this clinical trial (NCT07214571) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cutler Bay research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory syncytial virus infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all respiratory syncytial virus infections clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Cutler Bay, FL

See all rheumatoid arthritis clinical trials recruiting in Cutler Bay — not just this study.

Browse Rheumatoid Arthritis Trials in Cutler Bay

Ready to Join in Cutler Bay?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cutler Bay, FL